This evidence of G9a activity in MM is notable given that multiple studies have identified diverse molecular mechanisms by which G9a can contribute to carcinogenesis, tumor pathogenesis and poor survival outcomes in cancer patients [31]. This evidence concerns the gene EHMT2 and Miyoshi myopathy.